Innovation for Health - 13 February 2020
Contact Investor Forum I4H Bootcamp
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Luc Sterkman

CEO, Caelus Health

Session

14:45 - 15:35
Biotech breakthroughs

Luc Sterkman, MD (CEO) obtained his medical degree (MD) in 1988 at the Free University in Amsterdam. He has broad experience in the fields of general management, business development and R&D. From 1992-2002 he was COO and later CEO of U-Gene Research, that was successfully sold to Kendle USA (NASDAQ –KNDL). From 2002 to 2004, he worked as a Board member of the biotech company OctoPlus and from 2005 to 2010 he was General manager at the pharmaceutical company Disphar International BV (part of the Nordic Group). From 2011-2016 he worked as a COO at Newtricious, which company is focusing on innovative nutrition and functional foods. As the CEO at Caelus Health, he is since January 2016 overall responsible for building and directing the company in the next phase of growth and further expanding its pipeline of new microbiota-based products in the field of cardio-metabolic diseases.

Abstract

Microbiome-based therapeutics; a new rapidly growing field
Gut microorganisms, referred to as microbiota or microbiome, represent a broad and rapidly growing basis for new products and therapies based on individual microbiota or consortia of microorganisms and /or their metabolites. These products and therapies could help prevent or treat not only gastrointestinal disorders, but also address diseases in many clinical fields including oncology, dermatology, immunology and cardiovascular disorders.

Caelus Health is a company based on technologies of the Academic Medical Centre in Amsterdam and Wageningen University. The company is dedicated to developing microbiome-based therapeutics in cardio-metabolic disorders with an initial focus on Diabetes. Caelus has secured financial support from the Johnson & Johnson Development Corporation and performs its preclinical R&D at the well-established JLABS @ BE incubator and labs on the Janssen R&D campus in Beerse. Its first product is in Phase 2 clinical trials.
Mark van Houdenhoven
Sint Maartenskliniek
Mark van Houdenhoven
Troels Jordansen
Glycostem
Rob Kurver
KPN API store
Ton van der Steen
Erasmus MC Medical Delta

Marc Schellekens
LabHotel Rotterdam

Marc Schellekens
Ruben Kok
Dutch Techcentre for Life Sciences
Ruben Kok
Markwin Velders
Kite Pharma
Markwin Velders
Colja Laane
Mibiton
Colja Laane
Bert-Arjan Millenaar
NLC | The Healthtech Venture Builder
Bert-Arjan Millenaar
Annemiek Verkamman
HollandBIO
Claudia Wieringa
MSD
Joke Boonstra
Erasmus MC
Joke Boonstra
Ton de Boer
Medicines Evaluation Board
Anthonius de Boer
Onno van de Stolpe
Galapagos
Onno van de Stolpe

Kurt Gielen
Medace

Martijn Busstra
Erasmus MC
Ronald Stark
Netherlands strategic committee for Large-Scale Scientific Research Infrastructure
Ronald Stark
Joep de Groot
CbusineZ
Joep de Groot
Khatereh Ahmadi
MSD
Koos van der Hoeven
Radboud umc
Tom Miller
GreyBird Ventures
Tom Miller
Carine van den Brink
AXON Lawyers
Carine van den Brink
Eline Vrijland-van Beest
NightBalance
Eline Vrijland-van Beest
Edwin Moses
Ablynx
Edwin Moses
Maarten van Dongen
LabForRent
Maarten van Dongen

Eveline van Rijswijk
Science journalist & moderator

Jan de Kerpel
Kempen & Co
Jeff Gielen
Kadans Science Partner
Jeff Gielen

Arthur Lahr
Kiadis Pharma

Arthur Lahr
Paul Korte
Janssen

Will Ickenroth
Nemo Healthcare

Charlotte Kluit
MSD

Ton Rijnders
Lygature & Oncode Institute

André van de Sande
Interim Executive, Business Coach, Board Member

André van de Sande
Sangbreeta Moitra
Transform your Presence
Phil L'Huillier
MSD
Hans Schikan
Topsector LSH
Luc Sterkman
Caelus Health

Thomas Plochg
NPHF

Huib Kooijman
Ministry of Health

Peter Paul van Benthem
Dutch Association of Medical Specialists

Peter Paul van Benthem
Niels Chavannes
LUMC
Niels Chavannes

Zoraide Granchi
GenomeScan

Zoriade Granchi
Bert Leufkens
Utrecht University
Bert Leufkens

Maurits van Selms
ACTA

Maurits Selms
Chris van Hoof
imec
Chris van Hoof
Kees Recourt
Mibiton Foundation
Kees Recourt
Wiek van Gilst
UMCG
Wiek van Gilst
Marianne van der Steen
MERLN & RegMed XB
Marianne van der Steen
Stefan Braam
Ncardia
Stefan Braam
Werner Verbiest
Janssen Diagnostics
Werner Verbiest
Paul Vulto
Mimetas
Paul Vulto

Madelon Maurice
UMC Utrecht & Oncode Institute

Madelon Maurice
Rik Vos
Erasmus MC
Rik Vos
Eva van Rooijen
NLC | The Healthtech Venture Builder
Eva van Rooijen
Ingmar de Gooijer
myTomorrows
Ingmar de Gooijer
Eveliene Manten-Horst
AYA Jongvolwassen & Kanker
Eveliene Manten-Horst
Peter Hinssen
nexxworks
Peter Hinssen
Maaike Kleinsmann
TU Delft
Maaike Kleinsmann
Jos Malda
UMC Utrecht
Jos Malda
Nicolas Vergauwe
miDiagnostics
Nicolas Vergauwe

Henk van Houten
Royal Philips

Henk van Houten
Wietske Vrijland
Maasstad Ziekenhuis
Wietske Vrijland
Kurt Hertogs
Graphene.Works
Kurt Hertogs

Vladan Ilić
Westerdokters

Vladan Ilić

Koen Smits
Sioux
Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Sponsor
AXON Lawyers
Media sponsor
BiotechNEWS & Life Sciences
You?
Become a Sponsor!
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.